CareDx (CDNA) Tops Q3 EPS by 36c, Beats on Revenue; Offers FY25 Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
Tweet
Share
E-mailGet Alerts CDNA Hot Sheet
Join SI Premium – FREE
CareDx (NASDAQ: CDNA) reported Q3 EPS of $0.28, $0.36 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $100.1 million versus the consensus estimate of $95.32 million.
GUIDANCE:
CareDx sees FY2025 revenue of $372-376 million, versus the consensus of $368.9 million.
For earnings history and earnings-related data on CareDx (CDNA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Liberty Oilfield Services (LBRT) Misses Q3 EPS by 1c
- BancFirst Corp. (BANF) Tops Q3 EPS by 3c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
